- Previous Close
0.3800 - Open
0.4190 - Bid --
- Ask --
- Day's Range
0.3925 - 0.4190 - 52 Week Range
0.3925 - 0.4190 - Volume
1,408 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 2.79
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
www.quantum-si.comRecent News: QSIAW
View MoreCompare To: QSIAW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QSIAW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-24.85%
Return on Equity (ttm)
-41.48%
Revenue (ttm)
3.06M
Net Income Avi to Common (ttm)
-101.01M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
209.6M
Total Debt/Equity (mrq)
6.01%
Levered Free Cash Flow (ttm)
-54.4M